Persons Reported to be living with HIV infection and with AIDS reported

Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 6,640 23,869 236 125 6,876 23,994 30,509 361 30,870
2001

10,390

24,819

256 117 10,646 24,936 35,209 373 35,582
2002 14,764 27,249 350 109 15,114 27,358 42,013 459 42,472
                   

From February 1994 to December 1998, Texas reported only pediatric HIV infection cases.
 

HIV Infection Cases  from areas with confidential HIV infection reporting

Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 4,204 6,675 295 6,970
2001 4,237 10,495 320 10,815
2002 5,027 14,764 350 15,114
         

From February 1994 to December 1998, Texas reported only pediatric HIV infection cases.
 

Adult/Adolescent HIV infection and AIDS cases reported in the United States

Year Males Females
  HIV AIDS HIV AIDS
2000 2,989 2,113 1,179 543
2001 3,013 2,249 1,190 637
         

 

New Pediatric AIDS cases reported

Year
2000 11
2001 6

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through 2001

 

 1999

2000

2001

Cumulative Totals

City No No. No. Adults / Adolescents Children under 13 Years old Total

Austin

275 179 208 4,046 27 4,073
Dallas 626 647 749 13,082 37 13,119
El Paso 91 78 115 1,184 10 1,194
Fort Worth 133 189 132 3,364 26 3,390
Houston 927 687 801 19,735 163 19,898
McAllen 28 40 51 420 10 430
San Antonio 202 167 200 4,129 28 4,157

 


Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 59,772
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 59,380
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 392

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002

  TX USA
Men 50,768 680,909
Women 6,877 146,298
Total 57,645 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 3,140
New Adult/Adolescent AIDS Cases, Reported in 2001 2,886
New AIDS Cases in Children <13, Reported through December 2001 6

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001

  TX USA
Men 2,249 31,901
Women 637 11,082
Total 2,886 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 27,358
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 27,249
Estimated Number of Children Living with AIDS at the End of 2002 109
HIV Infection Cases Reported in 2002 5,027

 

Total Deaths Reported through 2000, due to AIDS = 31,181
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Anonymous and Confidential testing.
Definitions:
Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?
 
Providers required to test for HIV unless mother refuses. All health providers are required by law to conduct an HIV test unless the woman objects.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration?
NO,
Has considered or is considering an 1115 Waiver to expand Medicaid eligibility to people with HIV.
Definitions:
1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 

Sterile Syringe Exchange Programs?  Yes
Notes:
U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  No, If taught voluntarily must stress abstinence. State specifically authorizes localities to teach about contraception, but in North Carolina, New Jersey, and Texas, if taught, it must include failure rates or effectiveness and failure rates among adolescents.
 
Minors' Right to Consent to HIV/STD Services?  Yes. State explicitly classifies HIV/AIDS as an STD or infectious disease, for which minors may consent to testing and treatment. Physician may notify parents.
 

 

Total Ryan White Funding, FY2000   $105,679,537 FY2002  $127,712,408

 

CDC HIV Prevention Funding for States
 FY2001 
$13,858,060

FY2003   $13,932,861
 
Total Federal and State Funding for ADAP, FY2001  $57,294,626

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  TX
#
US
#
   6,318 80,035

 
ADAP Clients Served by Sex, June 2002  
  TX
#
TX
%
US
#
US
%
  Male 4,865 77 62,034 78
  Female 1,453 23 16,702 21
  Total 6,318 100 79,531 100


 

ADAP Clients Served by Race/Ethnicity, June 2002  
  TX
#
TX
%
US
#
US
%
  White 2,527 40 29,426 37
  Black 1,706 27 26,245 33
  Hispanic 2,022 32 19,883 25
  Asian/Pacific Islander 0 0 795 1
  American Indian/Alaskan Native 0 0 795 1
  Other 63 1 795 1
  Total 6,318 100 79,531 100

 
ADAP Clients Served by Age, June 2002  
  TX
#
TX
%
US
#
US
%
  <13 years old 32 1 795 1
  13-19 years old 32 1 0 1 0 1
  20-44 years old 4,296 68 50,105 63
  >44 years old 1,959 31 27,836 35
  Total 6,318 100 79,531 100

 
ADAP Clients Served by Income, June 2002  
  TX
#
TX
%
US
#
US
%
  <100% FPL 3,159 50 38,175 48
  101-200% FPL 2,527 40 26,245 33
  201-300% FPL 632 10 8,748 11
  301-400% FPL 0 0 3,181 4
  >400% FPL 0 0 1,591 2
  Total 6,318 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  TX
#
TX
%
US
#
US
%
  Medicaid 872 14 0 10
  Medicare 632 10 0 6
  Private 190 3 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  TX
$
US
$
   60,485,279 878,610,754

 
National ADAP Budget by Source, FY 2002  
  TX
$
TX
%
US
$
US
%
  ADAP Earmark 43,676,035 72 619,830,000 71
  Title II Base 0 0 28,886,192 3
  State 9,988,000 17 160,385,979 18
  Title I 269,723 0 19,736,619 2
  Other Federal 0 0 30,941,439 4
  ADAP Supplemental Grants 6,551,521 11 19,170,000 2
  Total 60,485,279 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  TX
$
US
$
   4,725,531 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  TX
$
TX
%
US
$
US
%
  Nucleoside Reverse Transcriptase Inhibitors 2,347,920 50 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 568,969 12 7,940,575 12
  Protease Inhibitors 1,411,121 30 16,433,502 25
  Opportunistic Infections/Other 397,521 8 9,015,329 14
  Total 4,725,531 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  TX
#
US
#
   17,059 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
  TX
#
TX
%
US
#
US
%
  Nucleoside Reverse Transcriptase Inhibitors 8,963 53 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 2,358 14 23,933 10
  Protease Inhibitors 3,478 20 33,813 15
  Opportunistic Infections/Other 2,260 13 87,746 38
  Total 17,059 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  TX
$
US
$
   NA 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  TX
#
US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 7 NA
  Other Medications Covered 11 NA